
Building well-being means the world to us.
Read moreStock exchange releases
- 6/23/2025 141,959 Orion Corporation A shares converted into B shares
- 5/2/2025 301,521 Orion Corporation A shares converted into B shares
- 4/24/2025 Composition of the Nomination Committee of Orion Corporation
- 4/23/2025 Orion Group Interim Report January–March 2025
Press releases
- 6/20/2025 CHMP recommends third indication for darolutamide for patients with advanced prostate cancer
- 6/17/2025 Orion and Glykos announce the extension of their research collaboration and licensing agreement for the development of next-generation ADCs
- 6/3/2025 U.S. FDA approves third indication of darolutamide for patients with advanced prostate cancer
- 5/23/2025 Orion announces agreement with Shilpa Medicare for Recombinant Human Albumin for European market